Fidelity Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-19
Closed 4179
2020
Q2
$0 Sell
19
-511,504
-100% ﹤0.01% 4418
2020
Q1
$3.65M Sell
511,523
-303,914
-37% -$2.17M ﹤0.01% 2028
2019
Q4
$19.5M Buy
815,437
+79,710
+11% +$1.9M ﹤0.01% 1604
2019
Q3
$19.7M Buy
735,727
+214,097
+41% +$5.74M ﹤0.01% 1577
2019
Q2
$14.2M Sell
521,630
-484,990
-48% -$13.2M ﹤0.01% 1758
2019
Q1
$34.9M Sell
1,006,620
-952
-0.1% -$33K ﹤0.01% 1371
2018
Q4
$19.7M Sell
1,007,572
-616,914
-38% -$12M ﹤0.01% 1556
2018
Q3
$43.3M Sell
1,624,486
-376,931
-19% -$10M ﹤0.01% 1336
2018
Q2
$75.6M Sell
2,001,417
-1,468
-0.1% -$55.4K 0.01% 1075
2018
Q1
$65.4M Sell
2,002,885
-2,242,361
-53% -$73.2M 0.01% 1173
2017
Q4
$207M Sell
4,245,246
-1,515,210
-26% -$73.8M 0.02% 684
2017
Q3
$311M Buy
5,760,456
+1,971,673
+52% +$107M 0.04% 500
2017
Q2
$213M Sell
3,788,783
-113,217
-3% -$6.36M 0.03% 664
2017
Q1
$153M Buy
3,902,000
+205,751
+6% +$8.06M 0.02% 811
2016
Q4
$82.9M Sell
3,696,249
-133,566
-3% -$3M 0.01% 1088
2016
Q3
$87M Sell
3,829,815
-2,492,156
-39% -$56.6M 0.01% 1044
2016
Q2
$149M Sell
6,321,971
-40,915
-0.6% -$966K 0.02% 791
2016
Q1
$130M Sell
6,362,886
-566,400
-8% -$11.6M 0.02% 860
2015
Q4
$357M Buy
6,929,286
+564,656
+9% +$29.1M 0.05% 420
2015
Q3
$271M Buy
6,364,630
+134,200
+2% +$5.72M 0.04% 497
2015
Q2
$284M Buy
6,230,430
+39,000
+0.6% +$1.78M 0.04% 521
2015
Q1
$235M Buy
6,191,430
+422,100
+7% +$16M 0.03% 616
2014
Q4
$163M Buy
5,769,330
+1,129,410
+24% +$32M 0.02% 772
2014
Q3
$117M Buy
4,639,920
+349,970
+8% +$8.85M 0.02% 895
2014
Q2
$125M Buy
4,289,950
+909,050
+27% +$26.5M 0.02% 877
2014
Q1
$87.6M Buy
3,380,900
+1,624,900
+93% +$42.1M 0.01% 1048
2013
Q4
$45.2M Buy
1,756,000
+768,500
+78% +$19.8M 0.01% 1365
2013
Q3
$26.4M Buy
987,500
+342,900
+53% +$9.17M ﹤0.01% 1592
2013
Q2
$15.8M Buy
+644,600
New +$15.8M ﹤0.01% 1749